The latest news for pharma industry insiders.
Addressing Data and Patient Retention Challenges
In a recent video interview with Applied Clinical Trials, Rachael Higgins, chief commercial officer, PicnicHealth, discussed the company’s recently released 2025 Annual State of Observational Research Report. She highlighted some of the key findings including the persistence of more traditional research methods as well as how patient retention and incomplete data are creating challenges for the industry.
Addressing Drug Shortages: A Call to Action for Pharmacists and Policy Makers
Managing the challenge requires a multifaceted approach with all stakeholders.
Europe Rapidly Falling Behind China in Pharma, AstraZeneca CEO Warns
Europe is fast losing its edge to China in pharmaceutical innovation, AstraZeneca Plc Chief Executive Officer Pascal Soriot warned.
Viz.ai announced new clinical data demonstrating how the Viz HCM module enables faster, accurate detection of signs of hypertrophic cardiomyopathy (HCM) to help ensure that more patients receive the care they need. Four studies, which will be presented at the American College of Cardiology’s Annual Scientific Session & Expo 2025, show the real-world impact of Viz.ai in clinical practice with earlier detection and triaging of new patients with HCM, a commonly inherited heart disease that often goes undetected.
#ICYMI: In the second part of her conversation with Pharmaceutical Executive, Kimberley Chiang, VP of biopharma commercial sales, leans into the actionable affordability strategies from the 2025 Medication Access Report, encouraging the industry to consider all dimensions of the patient journey.
By using predictive analytics and balancing digital advancement with clinical expertise, we can help patients access and afford the medicine they need to live healthier lives. Read now: https://bit.ly/4iK05nh
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs